Brief: AFT Pharmaceuticals Sees Operating Loss Of Just Under NZ$2 Mln For HY
Nov 1 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ :
* SEES OPERATING LOSS OF JUST UNDER NZ$2 MILLION FOR SIX
MONTHS
* EXPECTED FIRST HALF LOSS WILL LIKELY HAVE IMPACT ON
COMPANY'S
FULL YEAR GUIDANCE
* ANTICIPATES A RECOVERY IN SALES MOMENTUM IN TRADITIONALLY
STRONGER SECOND HALF OF FINANCIAL YEAR.
Source text: ID:n441065-2
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV